Medical Statistics and Epidemiology, P N Lee Statistics and Computing Ltd, Sutton, Surrey, UK.
Social and Behavioral Sciences, NYU School of Public Health, New York, NY.
Nicotine Tob Res. 2021 Feb 16;23(3):426-437. doi: 10.1093/ntr/ntaa102.
Various approaches have been used to estimate the population health impact of introducing a Modified Risk Tobacco Product (MRTP).
We aimed to compare and contrast aspects of models considering effects on mortality that were known to experts attending a meeting on models in 2018.
Thirteen models are described, some focussing on e-cigarettes, others more general. Most models are cohort-based, comparing results with or without MRTP introduction. They typically start with a population with known smoking habits and then use transition probabilities either to update smoking habits in the "null scenario" or joint smoking and MRTP habits in an "alternative scenario". The models vary in the tobacco groups and transition probabilities considered. Based on aspects of the tobacco history developed, the models compare mortality risks, and sometimes life-years lost and health costs, between scenarios. Estimating effects on population health depends on frequency of use of the MRTP and smoking, and the extent to which the products expose users to harmful constituents. Strengths and weaknesses of the approaches are summarized.
Despite methodological differences, most modellers have assumed the increase in risk of mortality from MRTP use, relative to that from cigarette smoking, to be very low and have concluded that MRTP introduction is likely to have a beneficial impact. Further model development, supplemented by preliminary results from well-designed epidemiological studies, should enable more precise prediction of the anticipated effects of MRTP introduction.
There is a need to estimate the population health impact of introducing modified risk nicotine-containing products for smokers unwilling or unable to quit. This paper reviews a variety of modeling methodologies proposed to do this, and discusses the implications of the different approaches. It should assist modelers in refining and improving their models, and help toward providing authorities with more reliable estimates.
为了评估引入改良风险烟草产品(MRTP)对人群健康的影响,人们采用了各种方法。
我们旨在比较和对比参加 2018 年模型会议的专家所了解的考虑对死亡率影响的模型的各个方面。
共描述了 13 种模型,有些侧重于电子烟,其他的则更为通用。大多数模型都是基于队列的,比较了引入 MRTP 前后的结果。它们通常从一个具有已知吸烟习惯的人群开始,然后使用转移概率来更新“基准情景”下的吸烟习惯,或者在“替代情景”下更新联合吸烟和 MRTP 习惯。这些模型在考虑的烟草组和转移概率方面有所不同。根据所开发的烟草史的各个方面,模型比较了情景之间的死亡率风险,有时还比较了丧失的寿命年数和健康成本。估计对人群健康的影响取决于 MRTP 的使用频率和吸烟情况,以及产品使使用者接触到有害成分的程度。方法的优缺点得到了总结。
尽管存在方法学差异,但大多数建模者都假设,与吸烟相比,MRTP 使用导致的死亡率风险增加非常低,并得出结论认为引入 MRTP 可能会产生有益的影响。进一步的模型开发,辅以精心设计的流行病学研究的初步结果,应该能够更精确地预测引入 MRTP 的预期影响。
需要估计对不愿意或无法戒烟的吸烟者引入改良风险含尼古丁产品对人群健康的影响。本文回顾了为此目的提出的各种建模方法,并讨论了不同方法的意义。它应该有助于建模者改进和完善他们的模型,并帮助当局提供更可靠的估计。